Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Inspiremd Inc (NSPR)

Inspiremd Inc (NSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Inspiremd Inc 4 MENORAT HAMAOR ST. TEL AVIV L3 6744832 ISR

www.inspiremd.com P: 888-776-6204

Description:

InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel.

Key Statistics

Overview:

Market Capitalization, $K 43,292
Enterprise Value, $K 33,652
Shares Outstanding, K 23,401
Annual Sales, $ 6,210 K
Annual Net Income, $ -19,920 K
Last Quarter Sales, $ 1,760 K
Last Quarter Net Income, $ -5,410 K
EBIT, $ -21,150 K
EBITDA, $ -20,920 K
60-Month Beta 0.83
% of Insider Shareholders 21.62%
% of Institutional Shareholders 44.78%
Float, K 18,342
% Float 78.38%
Short Volume Ratio 0.89

Growth:

1-Year Return 80.66%
3-Year Return -69.27%
5-Year Return -97.74%
5-Year Revenue Growth 72.50%
5-Year Earnings Growth 99.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 03/06/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -1.08
EPS Growth vs. Prev Qtr -6.67%
EPS Growth vs. Prev Year 73.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 04/27/21

NSPR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -55.71%
Return-on-Assets % -46.53%
Profit Margin % -320.77%
Debt/Equity 0.00
Price/Sales 7.45
Price/Cash Flow N/A
Price/Book 1.04
Book Value/Share 1.83
Interest Coverage -0.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar